OPEROSE HEALTH (GROUP) UK LIMITED
Get an alert when OPEROSE HEALTH (GROUP) UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-09-20 (in 4mo)
Last made up 2025-09-06
Watchouts
None on the register
Accounts
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Consolidated group
- Abridged
- Yes — abridged accounts (limited disclosure)
- Audit opinion
- Unaudited (audit-exempt)
- Going concern
- Affirmed
“The Directors have reviewed cash flow forecasts prepared at a consolidated level for a period of at least 12 months from the date of approval of these financial statements. These forecasts, which include reasonably possible downside scenarios, indicate that the Operose Health Group will have sufficient funds to meet its liabilities as they fall due. On this basis, the Directors consider it appropriate to prepare the financial statements on a going concern basis”
Significant events
- “During the prior period, as the Group moved towards focusing on primary and urgent care, the Group's community services division was closed, as these contracts came to the end of their natural contract length.”
- “£465k transaction and integration costs in 2024 reflect costs incurred in the change in ownership and subsequent review, reset and refocus of strategy resulting in some one off, non-recurrent costs as we implement and invest in new systems that would better help us to meet our strategic goals, realigned contracts and right-sized our corporate support functions.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 22 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HARDING, Nicholas John | Director | 2019-12-20 | Dec 1969 | British |
| MCKENZIE-BOYLE, Edward Charles Albert | Director | 2024-03-27 | Jan 1981 | English |
Show 22 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GODRICH, Francine | Secretary | 2012-04-24 | 2018-06-13 |
| HAMILL, William John | Secretary | 2011-11-28 | 2012-04-24 |
| HENDRIE, Neal Malcolm | Secretary | 2010-09-07 | 2011-08-12 |
| HUMPHREY, Shelley | Secretary | 2011-08-12 | 2011-11-28 |
| MILLEN, Karen Kai-Ling | Secretary | 2007-10-30 | 2010-09-07 |
| LAYTONS SECRETARIES LIMITED | Corporate Secretary | 2005-09-06 | 2007-10-30 |
| BRINKLEY, Cynthia Jane | Director | 2014-11-27 | 2016-01-18 |
| CHAN, Arvan See Wing | Director | 2016-01-18 | 2019-01-24 |
| DAVIES, Stephen John | Director | 2011-11-22 | 2013-04-02 |
| FORDYCE, Stuart Alistair | Director | 2008-05-27 | 2010-05-27 |
| HASTINGS, Roy | Director | 2014-05-30 | 2017-12-31 |
| HENDRIE, Neal Malcolm | Director | 2010-05-27 | 2011-08-12 |
| HOPKINS, Thomas William | Director | 2011-11-22 | 2014-04-22 |
| JOHNSON, Allan | Director | 2011-12-13 | 2018-01-31 |
| JONES, Samantha Geraldine | Director | 2019-01-24 | 2021-03-30 |
| KADIRGAMAR, Ajit Gordon Vimalendran, Dr | Director | 2005-09-06 | 2008-05-27 |
| MACFARLANE, Bruce Ferguson | Director | 2014-04-22 | 2016-09-29 |
| PERRY, Elizabeth Mary Louise | Director | 2021-03-29 | 2024-03-29 |
| RAVEN, Deborah Jane | Director | 2006-12-12 | 2011-10-14 |
| RHODES, Shaun Andrew | Director | 2006-10-10 | 2007-11-02 |
| ROSE, Jeremy David, Dr | Director | 2005-09-06 | 2019-12-31 |
| WATTS, Peter Martin | Director | 2005-09-06 | 2011-12-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Operose Health (Group) Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 141 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-18 | AA | accounts | Accounts with accounts type full | |
| 2026-04-03 | PARENT_ACC | accounts | Legacy | |
| 2026-04-03 | GUARANTEE2 | other | Legacy | |
| 2026-04-03 | RESOLUTIONS | resolution | Resolution | |
| 2025-09-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-11 | SH01 | capital | Capital allotment shares | |
| 2025-04-10 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-02 | AA | accounts | Accounts with accounts type total exemption full | |
| 2025-04-02 | PARENT_ACC | accounts | Legacy | |
| 2025-04-02 | AGREEMENT2 | other | Legacy | |
| 2025-04-02 | GUARANTEE2 | other | Legacy | |
| 2025-03-26 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-03-26 | SH20 | capital | Legacy | |
| 2025-03-26 | CAP-SS | insolvency | Legacy | |
| 2025-03-26 | RESOLUTIONS | resolution | Resolution | |
| 2024-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-08 | AA01 | accounts | Change account reference date company previous extended | |
| 2024-05-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-03-28 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
Latest filed period vs the prior one